120 related articles for article (PubMed ID: 11193386)
1. [Anti-carcinogenic structural modification by fluorine-substitution in aza-polycyclic aromatic hydrocarbons].
Saeki K
Yakugaku Zasshi; 2000 Dec; 120(12):1373-85. PubMed ID: 11193386
[TBL] [Abstract][Full Text] [Related]
2. Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice.
Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T; Suzuki T
Mutat Res; 1998 May; 414(1-3):165-9. PubMed ID: 9630605
[TBL] [Abstract][Full Text] [Related]
3. Modification of the carcinogenic potency of quinoline, a hepatocarcinogen, by fluorine atom substitution: evaluation of carcinogenicity by a medium-term assay.
Saeki K; Kadoi M; Kawazoe Y; Futakuchi M; Tiwawech D; Shirai T
Biol Pharm Bull; 1997 Jan; 20(1):40-3. PubMed ID: 9013804
[TBL] [Abstract][Full Text] [Related]
4. Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives.
Kato T; Hakura A; Mizutani T; Saeki K
Mutat Res; 2000 Feb; 465(1-2):173-82. PubMed ID: 10708984
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice.
Yamada K; Suzuki T; Kohara A; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2004 Apr; 559(1-2):83-95. PubMed ID: 15066577
[TBL] [Abstract][Full Text] [Related]
6. Dual stimulatory and inhibitory effects of fluorine-substitution on mutagenicity: an extension of the enamine epoxide theory for activation of the quinoline nucleus.
Saeki K; Kawai H; Kawazoe Y; Hakura A
Biol Pharm Bull; 1997 Jun; 20(6):646-50. PubMed ID: 9212983
[TBL] [Abstract][Full Text] [Related]
7. Effects of oligofluorine substitution on the mutagenicity of quinoline: a study with twelve fluoroquinoline derivatives.
Kato T; Saeki K; Kawazoe Y; Hakura A
Mutat Res; 1999 Feb; 439(2):149-57. PubMed ID: 10023045
[TBL] [Abstract][Full Text] [Related]
8. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
[TBL] [Abstract][Full Text] [Related]
10. Bioassay of quinoline, 5-fluoroquinoline, carbazole, 9-methylcarbazole and 9-ethylcarbazole in newborn mice.
Weyand EH; Defauw J; McQueen CA; Meschter CL; Meegalla SK; LaVoie EJ
Food Chem Toxicol; 1993 Oct; 31(10):707-15. PubMed ID: 8225128
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
12. Activation of the human Ah receptor by aza-polycyclic aromatic hydrocarbons and their halogenated derivatives.
Saeki K; Matsuda T; Kato TA; Yamada K; Mizutani T; Matsui S; Fukuhara K; Miyata N
Biol Pharm Bull; 2003 Apr; 26(4):448-52. PubMed ID: 12673023
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
14. The carcinogenicity of quinoline and benzoquinolines in newborn CD-1 mice.
LaVoie EJ; Shigematsu A; Rivenson A
Jpn J Cancer Res; 1987 Feb; 78(2):139-43. PubMed ID: 3104257
[TBL] [Abstract][Full Text] [Related]
15. Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene.
Bigger CA; Pontén I; Page JE; Dipple A
Mutat Res; 2000 May; 450(1-2):75-93. PubMed ID: 10838135
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of azaarenes.
Bleeker EA; Wiegman S; de Voogt P; Kraak M; Leslie HA; de Haas E; Admiraal W
Rev Environ Contam Toxicol; 2002; 173():39-83. PubMed ID: 11776750
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic activity of methyl- and fluoro-substituted derivatives of polycyclic aromatic hydrocarbons in a human hepatoma (HepG2) cell-mediated assay.
Diamond L; Cherian K; Harvey RG; DiGiovanni J
Mutat Res; 1984 Apr; 136(1):65-72. PubMed ID: 6425683
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study of aza-polycyclic aromatic hydrocarbons (aza-PAHs), modelling carbocations from oxidized metabolites and their covalent adducts with representative nucleophiles.
Borosky GL; Laali KK
Org Biomol Chem; 2005 Apr; 3(7):1180-8. PubMed ID: 15785805
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism of the aza polynuclear aromatic hydrocarbon dibenz[a,h]acridine by recombinant human and rat cytochrome P450s.
Yuan ZX; Kumar S; Sikka HC
Chem Res Toxicol; 2004 May; 17(5):672-8. PubMed ID: 15144224
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the mutagenicity of quinoline and all monohydroxyquinolines with a series of arene oxide, trans-dihydrodiol, diol epoxide, N-oxide and arene hydrate derivatives of quinoline in the Ames/Salmonella microsome test.
Willems MI; Dubois G; Boyd DR; Davies RJ; Hamilton L; McCullough JJ; van Bladeren PJ
Mutat Res; 1992 Apr; 278(4):227-36. PubMed ID: 1373859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
